In a growing number of people who contract COVID-19, symptoms persist long after the initial SARS-CoV-2 infection subsides. COVID-19 and long COVID patients display a variety of symptoms that reveal SARS-CoV-2’s versatility and its long-lasting impact on organ function. While this heterogeneity makes it difficult to study the disease, scientists apply every available technology to investigate the virus’ pathological mechanisms. In this webinar brought to you by Cayman Chemical, Floyd Chilton and Thomas Bumol will discuss how they combine metabolomics, transcriptomics, and immune profiling to study SARS-CoV-2’s ability to attack multiple organs, even after the virus has been cleared from the body.
Topics to be covered
Molecular networks and enzymes that determine COVID-19 mortality
Persistent inflammatory signatures in long COVID
Wednesday, November 17, 2021
3:00 - 4:30 PM Eastern Time
Meet the speakers
Floyd (Ski) H. Chilton, PhD Professor, School of Nutritional Sciences and Wellness Director, Precision Nutrition and Wellness Initiative The University of Arizona
Thomas F. Bumol, PhD Executive Vice President and Director
Allen Institute for Immunology
Sponsored by
Register
TS_Webinar_Bio-Rad_LabTools_Droplet Digital PCR: When qPCR Doesn’t Make the Cut November 4, 2021_IO#403220
You must have Javascript and Cookies enabled to access this webcast.
Information you provide will be shared with the sponsors for this content. The Scientist or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.
.png?width=990&name=40441_TS_Understanding-COVID-Long-Game-Webinar_Banner_JP_990x120%20(1).png "Understanding COVID Long Game")
